This recall has been initiated as a consequence of an out of specification outcome for readability noticed within the stability program.
The presence of the aluminum phosphate precipitate presents a possible danger that intravascular (I.V.) injection of product containing this precipitate may lead to blood vessel in
Source link
Home Public Health Agencies US Food and Drug Administration Jurox Incorporated is Voluntarily Recalling Two Lots of Alfaxan Unpreserved, an Intravenous...